Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT04612751 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04612751
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-02
- Primary completion
- 2026-05-04
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.